Pathstone Holdings »

Prime Medicine shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-03-31 $22k 11k 1.99
2024-12-31 $33k 11k 2.92
2024-09-30 $56k 14k 3.87

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Prime Medicine

Alphabet
T. Rowe Price Investment Management
BlackRock
ARK Investment Management
Vanguard Group
Farallon Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
D. E. Shaw & Co
MWG Management
Geode Capital Management

View all funds holding Prime Medicine